NEWSROOM Press Releases

    254 Results

    Biodesix Oral Presentation At SITC: Testing Methodology May Identify Primary Immunotherapy Resistance In Patients

    Biodesix is making an oral presentation at SITC regarding a testing methodology that may identify primary immunotherapy resistance in patients

    Media Advisory: Dr. Heinrich Roder, Biodesix CTO, To Speak At Precision Medicine World Conference

    Media Advisory: Dr. Heinrich Roder, Biodesix CTO, to speak at precision medicine world conference

    Biodesix Leaders Share Commercial and Pipeline Updates at Annual qPCR and dPCR Congress

    Biodesix leaders shared commercial and pipeline updates at the annual qPCR and dPCR Congress

    Biodesix Raises Add-On to Series G, Enters into Debt Refinancing Agreement with Innovatus Capital Partners; Scott Hutton Joins Biodesix

    Innovatus Capital partners joins as a new investor; Scott Hutton joins as COO

    Biodesix Announces PD-L1 Collaboration with Professor Fred R. Hirsch

    Biodesix and Professor Fred R. Hirsch announced a collaboration on a PD-L1 study

    Biodesix Announces New Data Demonstrating Analytic Validity of Automated RNA Extraction from Plasma with the GeneStrat® Test

    Biodesix announces new data, presented at AMP2017, supporting the analytic validity of automated RNA extraction with the GeneStrat test

    Data Published In AACR Journal Suggest Biodesix® Test in Development May Identify Melanoma Patients Who Could Benefit from Checkpoint Inhibitors

    Findings in the AACR Journal on melanoma patient outcomes after anti PD1 therapy; a serum protein signature predicted survival.

    Biodesix Blood-Based Diagnostic Testing Approach To PD-L1 Detection Shows Concordance with Immunohistochemistry

    Blood-based diagnostic approach to PD-L1 testing that shows concordance with immunohistochemistry; new data presented at EORTC

    Biodesix Announces Biomarker Research Collaboration with Checkmate Pharmaceuticals

    Biodesix announced a biomarker research collaboration with Checkmate Pharmaceuticals, using Biodesix's proprietary discovery platform, the Diagnostic Cortex

    Biodesix To Present Data at SITC Annual Meeting

    Biodesix will present posters and an oral presentation of data at SITC 2017 Annual Meeting.

    1 2 3 4 5 6 7 8 9